window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Genomics and sequencing

  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    Meteor Biotech joins South Korea consortium to advance brain organoid commercialisation platform

    Meteor Biotech has joined a South Korean government-backed consortium aimed [...]

    June 23, 2026
  • Advanced Therapies,Clinical & Regulatory,Genomics and sequencing,Therapeutic Areas

    Atsena advances gene therapy ATSN-201 into Phase 3 trial for inherited blindness

    Atsena Therapeutics has dosed the first patient in the Phase [...]

    June 22, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Genomics and sequencing,Pharmaceuticals and therapeutics,Therapeutic Areas

    Scribe Therapeutics secures $25M CIRM backing to advance CRISPR cardiometabolic therapies

    Scribe Therapeutics has secured more than $25 million in CIRM [...]

    June 18, 2026
  • Digital & Data,Genomics and sequencing

    Wellcome Genome Campus expands AI and genomics ambitions with new advisory group

    The Wellcome Genome Campus has established a Science and Technology [...]

    June 18, 2026
  • Biotech & Pharma Business,Drug Delivery & Formulation,Drug Discovery & Development,Genomics and sequencing

    European WiFIX consortium wins €1m Eurostars grant for Nexopore nucleic acid delivery technology

    A European consortium has secured a €1m Eurostars grant to [...]

    June 10, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Genomics and sequencing

    10x Genomics acquires Proteintech Genomics to expand single-cell proteomics capabilities

    10x Genomics has acquired Proteintech Genomics, a division within Proteintech [...]

    June 10, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Genomics and sequencing

    Countable Labs raises $26m to expand Countable PCR platform

    Countable Labs has raised $26 million in an oversubscribed financing [...]

    June 6, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    23andMe study links genetics to GLP-1 weight loss outcomes and side effects

    This Nature-published study from the 23andMe Research Institute identifies genetic [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    Primerdesign and Origin partner on rectal mucus DNA extraction for colorectal cancer detection

    Primerdesign and Origin Sciences partner to develop a DNA extraction [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Genomics and sequencing,Therapeutic Areas

    Circio presents new in vivo data showing enhanced circVec-AAV gene expression in eye

    Circio Holding ASA, a biotechnology company developing circular RNA-based gene [...]

    May 5, 2026
Previous234Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Eleva separates biologics platform from Factor H therapy
    Categories: Advanced Therapies, Biotech & Pharma Business, Pharmaceuticals and therapeutics, Research & Development
  • ENA Respiratory begins Phase 2a dosing of nasal antiviral INNA-051
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Circio raises NOK 200M (€18.6M) to advance in vivo CAR-T programme
    Categories: Advanced Therapies, Biotech & Pharma Business, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top